Reza Mansouri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Reza Mansouri has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Minoosh Moghimi
Department of Hematology-Oncology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
3 shared publications - Farzane Ahmadi
Department of Biostatistics and Epidemiology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
2 shared publications - Kasra Khodadadi
Liver and Gastrointestinal Diseases Research Center, Emam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran
2 shared publications Majid Amirian
Borna Research and Medical Laboratory, Zanjan, Iran
2 shared publications- Mohammad Borna Amirian
Borna Research and Medical Laboratory, Zanjan, Iran
2 shared publications Shahin Vadoudi
Department of Internal Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
2 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in International Journal of Breast Cancer
- Vol. 2025 (1) , 8209394
Androgen Receptor and Tumor‐Associated Neutrophil Expression Across Breast Cancer Subtypes: Associations With Clinicopathological Characteristics
Objectives: This study is aimed at evaluating androgen receptor (AR) and tumor‐associated neutrophil (TAN) expressions in different breast cancer subtypes and their relationship with tumor differentiation, stage, and other clinicopathological markers. Methods: A cross‐sectional study was conducted on 84 breast cancer patients at Stages I–IV. Tumor tissues were assessed using immunohistochemistry for ER, PR, HER2, AR, and Ki67, along with TAN evaluation using hematoxylin and eosin staining. Associations between AR, TAN, and other clinical variables were analyzed using chi‐square, t ‐tests, and logistic regression. Results: AR was expressed in 70.2% of tumors and was significantly associated with ER positivity (OR = 74.31, p < 0.001), PR positivity (OR = 6.8, p = 0.01), and better differentiation (OR = 0.1 for poorly differentiated tumors, p = 0.035). AR positivity was highest in Luminal A/B subtypes (82%) and lowest in triple‐negative breast cancer (TNBC) (20%; OR = 0.06, 95% CI: 0.01–0.3). In contrast, TAN positivity was observed in 45.6% of cases and was most frequent in TNBC (67%; OR = 3.7, 95% CI: 0.9–15.3) and poorly differentiated tumors (71.4%). TANs were inversely associated with PR positivity (OR = 0.21, p = 0.014) and showed a significant association with vascular invasion ( p = 0.047). No significant associations were found between AR or TAN expression and metastatic status or neural invasion. Conclusion: AR is a defining marker for HR‐positive breast cancers and may serve as an indicator of lower tumor grade and differentiation status. TANs, however, are linked to more aggressive phenotypes, especially in TNBC, suggesting a role in driving tumor progression. This highlights the potential for AR and TAN expression patterns to refine patient stratification across breast cancer subtypes.
- 1 January 2025
- Published by Wiley in International Journal of Breast Cancer
- Vol. 2025 (1) , 8209394
Open AccessAndrogen Receptor and Tumor‐Associated Neutrophil Expression Across Breast Cancer Subtypes: Associations With Clinicopathological Characteristics
Objectives: This study is aimed at evaluating androgen receptor (AR) and tumor‐associated neutrophil (TAN) expressions in different breast cancer subtypes and their relationship with tumor differentiation, stage, and other clinicopathological markers. Methods: A cross‐sectional study was conducted on 84 breast cancer patients at Stages I–IV. Tumor tissues were assessed using immunohistochemistry for ER, PR, HER2, AR, and Ki67, along with TAN evaluation using hematoxylin and eosin staining. Associations between AR, TAN, and other clinical variables were analyzed using chi‐square, t ‐tests, and logistic regression. Results: AR was expressed in 70.2% of tumors and was significantly associated with ER positivity (OR = 74.31, p < 0.001), PR positivity (OR = 6.8, p = 0.01), and better differentiation (OR = 0.1 for poorly differentiated tumors, p = 0.035). AR positivity was highest in Luminal A/B subtypes (82%) and lowest in triple‐negative breast cancer (TNBC) (20%; OR = 0.06, 95% CI: 0.01–0.3). In contrast, TAN positivity was observed in 45.6% of cases and was most frequent in TNBC (67%; OR = 3.7, 95% CI: 0.9–15.3) and poorly differentiated tumors (71.4%). TANs were inversely associated with PR positivity (OR = 0.21, p = 0.014) and showed a significant association with vascular invasion ( p = 0.047). No significant associations were found between AR or TAN expression and metastatic status or neural invasion. Conclusion: AR is a defining marker for HR‐positive breast cancers and may serve as an indicator of lower tumor grade and differentiation status. TANs, however, are linked to more aggressive phenotypes, especially in TNBC, suggesting a role in driving tumor progression. This highlights the potential for AR and TAN expression patterns to refine patient stratification across breast cancer subtypes.
- Open Access
- 20 April 2024
- Published by Springer Nature in BMC Pediatrics
- Vol. 24 (1) , 1-12
The impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: a single-blind randomized clinical trial
Background: Respiratory distress syndrome (RDS) is one of the most important and common disorders among premature infants. Objective: This study aimed to compare the effect of the combination of surfactant and budesonide with surfactant alone on Bronchopulmonary dysplasia (BPD) and mortality rate among premature infants with RDS. Method: An outcome assessor-blind randomized clinical trial was conducted on 134 premature infants with RDS who were born in Ayatollah Mousavi Hospital, Zanjan, Iran in 2021. The covariate adaptive randomization method was utilized to allocate participants into two groups (surfactant alone and a combination of surfactant and budesonide). The primary outcomes were BPD and Mortality rate from admission to hospital discharge. The data in this study were analyzed using SPSS software version 18. Results: Overall the comparison of mortality rate and BPD between the two groups did not show a significant difference(p > 0.05). The subgroup results showed that administering surfactant with budesonide to infants under 30 weeks of age significantly reduced the number of deaths compared to using surfactant alone (5 vs. 17). Similar positive effects were observed for the occurrence of Pulmonary Hemorrhage, the need for a second dose of surfactant, oxygen index, mean blood pressure and mean arterial pressure (MAP) in infants under 34 weeks of age compared to more than 34 weeks (p < 0.05). Conclusion: These findings suggest that the combination therapy of surfactant and budesonide may be beneficial, particularly in preterm infants with less than 34 weeks gestational age and 1500 birth weight. However, further studies with larger sample sizes and longer follow-up periods are needed to confirm these results and assess long-term outcomes. Trial registration: The study was registered at the Iranian Registry of Clinical Trials website under the code IRCT20201222049802N1. https://en.irct.ir/user/trial/48117/view. Registration date: 28/02/2021. Public repository: Data set: This research data set link is displayed on the Zanjan-Iran Medical Sciences website: https://repository.zums.ac.ir/cgi/users/login? target=https%3 A%2 F/repository.zums.ac.ir/id/eprint.
- 20 April 2024
- Published by Springer Nature in BMC Pediatrics
- Vol. 24 (1) , 1-12
Open AccessThe impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: a single-blind randomized clinical trial
Background: Respiratory distress syndrome (RDS) is one of the most important and common disorders among premature infants. Objective: This study aimed to compare the effect of the combination of surfactant and budesonide with surfactant alone on Bronchopulmonary dysplasia (BPD) and mortality rate among premature infants with RDS. Method: An outcome assessor-blind randomized clinical trial was conducted on 134 premature infants with RDS who were born in Ayatollah Mousavi Hospital, Zanjan, Iran in 2021. The covariate adaptive randomization method was utilized to allocate participants into two groups (surfactant alone and a combination of surfactant and budesonide). The primary outcomes were BPD and Mortality rate from admission to hospital discharge. The data in this study were analyzed using SPSS software version 18. Results: Overall the comparison of mortality rate and BPD between the two groups did not show a significant difference(p > 0.05). The subgroup results showed that administering surfactant with budesonide to infants under 30 weeks of age significantly reduced the number of deaths compared to using surfactant alone (5 vs. 17). Similar positive effects were observed for the occurrence of Pulmonary Hemorrhage, the need for a second dose of surfactant, oxygen index, mean blood pressure and mean arterial pressure (MAP) in infants under 34 weeks of age compared to more than 34 weeks (p < 0.05). Conclusion: These findings suggest that the combination therapy of surfactant and budesonide may be beneficial, particularly in preterm infants with less than 34 weeks gestational age and 1500 birth weight. However, further studies with larger sample sizes and longer follow-up periods are needed to confirm these results and assess long-term outcomes. Trial registration: The study was registered at the Iranian Registry of Clinical Trials website under the code IRCT20201222049802N1. https://en.irct.ir/user/trial/48117/view. Registration date: 28/02/2021. Public repository: Data set: This research data set link is displayed on the Zanjan-Iran Medical Sciences website: https://repository.zums.ac.ir/cgi/users/login? target=https%3 A%2 F/repository.zums.ac.ir/id/eprint.
- 1 June 2023
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 41 (16_suppl) , e12539
Simultaneous expression of androgen receptor and tumor-associated neutrophil in breast cancer subtypes.
- 1 June 2023
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 41 (16_suppl) , e12539
Simultaneous expression of androgen receptor and tumor-associated neutrophil in breast cancer subtypes.
- Open Access
- 18 June 2020
- Published by Springer Nature in Research Square
Case Report of 78 –year-old man with meningitis, Pulmonary Thromboembolism & SARS-Coronavirus-2 infection
The novel corona virus infection involve both Central & Peripheral Nervous System . Some of the presentations include: acute cerebrovascular disease, impaired consciousness, transverse myelitis, encephalopathy, encephalitis and epilepsy. Our patient was 78 year –old man with dementia and diabetic nephropathy which was admitted two times for possibly COVID19 infection. At the first hospitalization, the patient is treated with hydroxychloroquine and kaletra based on clinical symptoms and initial laboratory findings due to suspicion of COVID19 . After the negative RT-PCR test of nasopharyngeal sample for covid19 and evidence of aspiration pneumonia in CT scan, the patient was discharged with oral antibiotics. Five weeks later, he was rehospitalized with loss of consciousness, fever and hypoxemia in physical exam he had neck stiffness in all directions, So the CNS infection was suspected, the CSF sample was in favor of aseptic meningitis and second RT-PCR test of nasopharyngeal sample for COVID19 was positive but Brain MRI just showed small vessel disease without evidence of encephalitis. In the second hospitalization, he had acute renal failure, which was treated with supportive care, and also suffered from pulmonary embolism with cavitary lesions in his lungs. Meningitis with pulmonary embolism and acute renal failure have not yet reported. Our patient is the first one, so we decided to share it. This case showed different presentation of COVID19 without typical lung involvement. So we must pay attention to any sign & symptoms in a patient suspected of having a COVID19 .
- 18 June 2020
- Published by Springer Nature in Research Square
Open AccessCase Report of 78 –year-old man with meningitis, Pulmonary Thromboembolism & SARS-Coronavirus-2 infection
The novel corona virus infection involve both Central & Peripheral Nervous System . Some of the presentations include: acute cerebrovascular disease, impaired consciousness, transverse myelitis, encephalopathy, encephalitis and epilepsy. Our patient was 78 year –old man with dementia and diabetic nephropathy which was admitted two times for possibly COVID19 infection. At the first hospitalization, the patient is treated with hydroxychloroquine and kaletra based on clinical symptoms and initial laboratory findings due to suspicion of COVID19 . After the negative RT-PCR test of nasopharyngeal sample for covid19 and evidence of aspiration pneumonia in CT scan, the patient was discharged with oral antibiotics. Five weeks later, he was rehospitalized with loss of consciousness, fever and hypoxemia in physical exam he had neck stiffness in all directions, So the CNS infection was suspected, the CSF sample was in favor of aseptic meningitis and second RT-PCR test of nasopharyngeal sample for COVID19 was positive but Brain MRI just showed small vessel disease without evidence of encephalitis. In the second hospitalization, he had acute renal failure, which was treated with supportive care, and also suffered from pulmonary embolism with cavitary lesions in his lungs. Meningitis with pulmonary embolism and acute renal failure have not yet reported. Our patient is the first one, so we decided to share it. This case showed different presentation of COVID19 without typical lung involvement. So we must pay attention to any sign & symptoms in a patient suspected of having a COVID19 .
- Open Access
- 1 January 2017
- Published by ScopeMed in Journal of Research in Medical and Dental Science
- Vol. 5 (2) , 80
Hydrogen Peroxide Tooth Whitening Agent Alters the Protein Content of Enamel
- 1 January 2017
- Published by ScopeMed in Journal of Research in Medical and Dental Science
- Vol. 5 (2) , 80
Open AccessHydrogen Peroxide Tooth Whitening Agent Alters the Protein Content of Enamel
- Open Access
- 28 January 2016
- Published by American Physical Society (APS) in Physical Review D
- Vol. 93 (2) , 023007
Relativistic virial relation for cosmological structures
Starting with the relativistic Boltzmann equation for a system of particles defined by a distribution function, we have derived the virial relation for a spherical structure within an expanding background in the context of general relativity. This generalized form of the virial relation is then applied to the static case of a spherically symmetric structure to see the difference in the simplest case to the Newtonian relation. A relativistic mass-temperature relation for this simple case is also derived which can be applied to compact objects in astrophysics. Our general virial relation is then applied to the nonstatic case of a structure within an expanding universe where an extra term, usually missed in studies of structures in the presence of the dark energy, appears.
- 28 January 2016
- Published by American Physical Society (APS) in Physical Review D
- Vol. 93 (2) , 023007
Open AccessRelativistic virial relation for cosmological structures
Starting with the relativistic Boltzmann equation for a system of particles defined by a distribution function, we have derived the virial relation for a spherical structure within an expanding background in the context of general relativity. This generalized form of the virial relation is then applied to the static case of a spherically symmetric structure to see the difference in the simplest case to the Newtonian relation. A relativistic mass-temperature relation for this simple case is also derived which can be applied to compact objects in astrophysics. Our general virial relation is then applied to the nonstatic case of a structure within an expanding universe where an extra term, usually missed in studies of structures in the presence of the dark energy, appears.
- Open Access
- 1 July 1993
- Published by IOP Publishing in Classical and Quantum Gravity
- Vol. 10 (7) , 1353-1359
Tunnelling in anisotropic cosmological models
The tunnelling rate is investigated in homogeneous and anisotropic cosmologies. The calculations are performed by two methods: Euclidean and Hamiltonian approaches. It is found that the probability decreases exponentially as anisotropy is increased.
- 1 July 1993
- Published by IOP Publishing in Classical and Quantum Gravity
- Vol. 10 (7) , 1353-1359
Open AccessTunnelling in anisotropic cosmological models
The tunnelling rate is investigated in homogeneous and anisotropic cosmologies. The calculations are performed by two methods: Euclidean and Hamiltonian approaches. It is found that the probability decreases exponentially as anisotropy is increased.